Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Neuromuscular Disorders : NMD
|
September 1, 1995
A severe muscular dystrophy patient with an internally deleted very short (110 kD) dystrophin: presence of the binding site for dystrophin-associated glycoprotein (DAG) may not be enough for physiological function of dystrophin
E Arikawa-Hirasawa, R Koga, T Tsukahara, et al.
Neuromuscular Disorders : NMD
|
May 1, 1994
Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies
S Orimo, R Koga, K Goto, et al.
Nature Genetics
|
March 1, 1996
Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy
A Nagano, R Koga, M Ogawa, et al.
Nihon Sanka Fujinka Gakkai Zasshi
|
November 1, 1984
[Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer]
E Kimura, M Murae, R Koga, et al.
Genes and Immunity
|
March 6, 2003
Aberrant HS1 molecule in a patient with systemic lupus erythematosus
T Sawabe, T Horiuchi, R Koga, et al.
The Journal of Nutrition
|
April 26, 2013
Dietary choline and betaine intakes vary in an adult multiethnic population
Kim M Yonemori, Unhee Lim, Karin R Koga, et al.
Nature
|
September 28, 2001
Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
M Jutel, T Watanabe, S Klunker, et al.
International Journal of Cancer
|
June 2, 2011
Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies
Shannon M Conroy, Christy G Woolcott, Karin R Koga, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 1999
Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3-and 5-end-modification, with anti-HIV-1 activity
M Koizumi, R Koga, H Hotoda, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Biologically active oligodeoxyribonucleotides. 5. 5'-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure
H Hotoda, M Koizumi, R Koga, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Neuromuscular Disorders : NMD
|
September 1, 1995
A severe muscular dystrophy patient with an internally deleted very short (110 kD) dystrophin: presence of the binding site for dystrophin-associated glycoprotein (DAG) may not be enough for physiological function of dystrophin
E Arikawa-Hirasawa, R Koga, T Tsukahara, et al.
Neuromuscular Disorders : NMD
|
May 1, 1994
Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies
S Orimo, R Koga, K Goto, et al.
Nature Genetics
|
March 1, 1996
Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy
A Nagano, R Koga, M Ogawa, et al.
Nihon Sanka Fujinka Gakkai Zasshi
|
November 1, 1984
[Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer]
E Kimura, M Murae, R Koga, et al.
Genes and Immunity
|
March 6, 2003
Aberrant HS1 molecule in a patient with systemic lupus erythematosus
T Sawabe, T Horiuchi, R Koga, et al.
The Journal of Nutrition
|
April 26, 2013
Dietary choline and betaine intakes vary in an adult multiethnic population
Kim M Yonemori, Unhee Lim, Karin R Koga, et al.
Nature
|
September 28, 2001
Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
M Jutel, T Watanabe, S Klunker, et al.
International Journal of Cancer
|
June 2, 2011
Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies
Shannon M Conroy, Christy G Woolcott, Karin R Koga, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 1999
Biologically active oligodeoxyribonucleotides. Part 11: The least phosphate-modification of quadruplex-forming hexadeoxyribonucleotide TGGGAG, bearing 3-and 5-end-modification, with anti-HIV-1 activity
M Koizumi, R Koga, H Hotoda, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Biologically active oligodeoxyribonucleotides. 5. 5'-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure
H Hotoda, M Koizumi, R Koga, et al.
Page
of 6